£109.50

Prescription Drug Pricing: Background, Discount Programs and Cost Lowering Strategies (Pharmacology - Research, Safety Testing and Regulation)

Pharmacy - Dispensing

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£110 today · previous high £110 · all-time low £109

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days · 90 data points

Historical

Generating forecast…

Price Distribution

Price distribution over 90 days • 1 price levels

Days at Price

Price Analysis

Most common price: £109 (90 days, 100.0%)

Price range: £109 - £109

Price levels: 1 different prices over 90 days

Description

Chapter 1 examines the actions of drug companies in raising prescription drug prices in the United States, as well as the effects of these actions on the Federal and state budgets, and on American families. Chapter 2 addresses frequently asked questions about government and private-sector policies that affect drug prices and availability. Among the prescription drug topics covered are federally funded research and development, regulation of direct-to-consumer advertising, legal restrictions on reimportation, and federal price negotiation. The 340B Drug Pricing Program requires drug manufacturers to sell outpatient drugs at discounted prices to covered entities-eligible clinics, hospitals, and others-in order to have their drugs covered by Medicaid. Covered entities are only allowed to provide 340B drugs to certain eligible patients. Chapter 3 reviews the Health Resources and Services Administration's (HRSA) oversight of the 340B Program to ensure compliance with program rules. In 2017, nearly 60% of U.S. adults aged 18-64 reported being prescribed medication in the past 12 months. Approximately 70% of prescription medications carry out-of-pocket costs. Strategies to reduce prescription drug costs at the individual level are discussed in chapters 4 and 5. Each year, Americans pay more for prescription drugs, and rising drug prices have a disproportionate impact on older Americans. Chapter 6 examines the history of rising drug prices for the brand-name drugs most commonly prescribed for seniors. Generic drugs-copies of brand-name drugs-lead to significant cost savings. Before a generic drug can be marketed, FDA must approve the generic drug application. According to FDA, applications go through an average of three cycles of review before being approved, which may take years. Chapter 7 examines 1) the first review cycle approval rate of generic drug applications in recent years and factors that may have contributed to whether applications were approved; and 2) changes FDA has made to increase the first review cycle approval rate.

Product Specifications

Format: paperback
ASIN: 1536176680
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 13 March 2020
Listed Since: 08 February 2020

Barcode

No barcode data available

Prescription Drug Pricing: Background, Discount Programs and Cost Lowering Strategies (Pharmacology - Research, Safety Testing and Regulation)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Medicaid Prescription Drugs: Pricing & Policy Issues

Prescription Drugs: Monitoring, Safety, Use and Management Programs (Pharmacology -- Research, Safety Testing and Regulation)

SNOVA - The Price of Prescription Medicine Book

The 2023 Report on Prescription Drugs: World Market Segmentation by City

MODERN PHARMACOTHERAPY PRACTICE: The Prescriber’s Guide to Principles, Drug Selection, and Therapeutic Regimens

Consumers Guide to Prescription & Over the Counter

The 2016-2021 Outlook for Generic Prescription Drugs in the United States

Revolutionizing Pharmaceuticals With AI-Driven Drug Discovery, Design, and Development

The 2016-2021 Outlook for Generic Prescription Drugs in Greater China

Analyse des erreurs de prescription et de dispensation à l'officine: Erreurs médicamenteuses

Nova Science Pharmaceutical Formulation & Medicinal Chemistry

Medicare’s Prescription Drug Pricing: Inflation, Challenges and Affordability (Health Care in Transition)

A Screenful of Sugar? - Prescription Drug Websites - 10 Books

Medicare Part D Prescription Drug Benefit: Elements, Provisions & Integrity Issues

Overview of the Global Pharmaceutical Industry and New Drug Market Trends – Part II. Therapeutics by Disease Area: DATABOOK 2024, Part II. Analysis of Prescription Drugs by Therapeutic Area

Promising Pharmaceuticals

Modern Dispensing and Hospital Pharmacy

Drug Repurposing: Novel Therapeutic Avenues and Innovations in Healthcare (Chemistry Research and Applications)

FORTGESCHRITTENE PHARMAKOLOGIE FÜR VERSCHREIBER: Unverzichtbarer Leitfaden für evidenzbasiertes Medikamentenmanagement bei erfahrenen Gesundheitsdienstleistern

The 2016-2021 Outlook for Generic Prescription Drugs in Japan

The 2025-2030 World Outlook for Generic Prescription Drugs

Drug Repurposing: Hypothesis, Molecular Aspects and Therapeutic Applications

グローバル製薬産業の現状と新薬市場の動向企業編: ファーマセット・リサーチ DATABOOK 2024

Principles and Practice of Pharmacotherapy: Foundations, Therapeutic Strategies, and Clinical Applications in Modern Medicine